1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Pharmacokinetics of valganciclovir and ganciclovir in renal impairment.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Valganciclovir is the oral prodrug of ganciclovir. The pharmacokinetics of valganciclovir in patients with renal impairment is not known. Furthermore, it is not known whether there are any pharmacokinetic differences between patients who are positive for human immunodeficiency virus (HIV) and cytomegalovirus (CMV) and healthy subjects.

          Related collections

          Author and article information

          Journal
          Clin. Pharmacol. Ther.
          Clinical pharmacology and therapeutics
          Elsevier BV
          0009-9236
          0009-9236
          Aug 2002
          : 72
          : 2
          Affiliations
          [1 ] Division of Nephrology, Internal Medicine II, University Hospital Ulm, Robert-Koch-Strasse 8, 89081 Ulm, Germany. david.czock@medizin.uni-ulm.de
          Article
          S0009923602000358
          10.1067/mcp.2002.126306
          12189361
          c67f33c3-27bc-48cb-8aa7-09d690a5d4c1
          History

          Comments

          Comment on this article